
medimix.be
Dec 23, 2024, 20:37
Guilherme Nader Marta: Two perspectives on anthracycline use in breast cancer
Guilherme Nader Marta, Clinical Fellow at Dana-Farber Cancer Institute, shared a post on LinkedIn:
“Honoured to share our article in the NEJM Group Breast Cancer Update discussing two perspectives on anthracycline use in breast cancer—a long-debated topic that remains highly relevant today.
Grateful to co-author this work with Martine Piccart.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 11, 2025, 16:48
Mar 11, 2025, 16:33
Mar 11, 2025, 16:24
Mar 11, 2025, 15:02
Mar 11, 2025, 14:44
Mar 11, 2025, 14:12
Mar 11, 2025, 13:57